Shares of Ocugen Inc. /zigman2/quotes/208160861/composite OCGN -7.10% slipped 5.10% to $7.26 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -1.01% rising 0.34% to 4,704.54 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.08% falling 0.17% to 35,870.95. This was the stock's fourth consecutive day of losses. Ocugen Inc. closed $11.51 short of its 52-week high ($18.77), which the company reached on February 8th.
The stock underperformed when compared to some of its competitors Thursday, as Adverum Biotechnologies Inc. /zigman2/quotes/210484271/composite ADVM -5.00% fell 4.23% to $2.04, Ocular Therapeutix Inc. /zigman2/quotes/207607068/composite OCUL -3.64% remained unchanged, and Kodiak Sciences Inc. /zigman2/quotes/207655028/composite KOD -5.95% fell 1.41% to $100.66. Trading volume (13.9 M) remained 24.2 million below its 50-day average volume of 38.1 M.